Shay Bujanover

1.1k total citations
33 papers, 308 citations indexed

About

Shay Bujanover is a scholar working on Cognitive Neuroscience, Experimental and Cognitive Psychology and Physiology. According to data from OpenAlex, Shay Bujanover has authored 33 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cognitive Neuroscience, 17 papers in Experimental and Cognitive Psychology and 15 papers in Physiology. Recurrent topics in Shay Bujanover's work include Sleep and Wakefulness Research (21 papers), Sleep and related disorders (15 papers) and Obstructive Sleep Apnea Research (14 papers). Shay Bujanover is often cited by papers focused on Sleep and Wakefulness Research (21 papers), Sleep and related disorders (15 papers) and Obstructive Sleep Apnea Research (14 papers). Shay Bujanover collaborates with scholars based in United States, France and Sweden. Shay Bujanover's co-authors include Kathleen F. Villa, Carl Stepnowsky, Natalia M. Flores, Morgan Bron, Kathleen Sarmiento, Vicky W. Li, Alan M. Rapoport, Cuiping Chen, Jed Black and Sairam Parthasarathy and has published in prestigious journals such as Neurology, Pain and SLEEP.

In The Last Decade

Shay Bujanover

32 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shay Bujanover United States	11	180	173	157	117	30	33	308
Bianca Pivetta Canada	6	186 1.0×	53 0.3×	72 0.5×	113 1.0×	69 2.3×	12	264
S. Pejovic Greece	3	195 1.1×	109 0.6×	164 1.0×	194 1.7×	44 1.5×	4	338
Anne‐Cécile Troussière France	5	116 0.6×	83 0.5×	35 0.2×	54 0.5×	14 0.5×	6	198
Timothy V. Coy United States	7	235 1.3×	73 0.4×	79 0.5×	179 1.5×	75 2.5×	8	328
Michael Yurcheshen United States	6	63 0.3×	57 0.3×	72 0.5×	63 0.5×	11 0.4×	11	176
Paul P. Doghramji United States	10	63 0.3×	73 0.4×	107 0.7×	64 0.5×	15 0.5×	24	262
Ainhoa Álvarez Ruiz De Larrínaga Spain	6	146 0.8×	37 0.2×	47 0.3×	106 0.9×	68 2.3×	17	237
C. LʼHéritier France	9	60 0.3×	87 0.5×	80 0.5×	21 0.2×	19 0.6×	14	300
Margalida Bosch Spain	5	616 3.4×	155 0.9×	120 0.8×	505 4.3×	208 6.9×	5	691
Liangjun Dang China	10	136 0.8×	43 0.2×	34 0.2×	19 0.2×	20 0.7×	34	295

Countries citing papers authored by Shay Bujanover

Since Specialization

Citations

This map shows the geographic impact of Shay Bujanover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shay Bujanover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shay Bujanover more than expected).

Fields of papers citing papers by Shay Bujanover

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shay Bujanover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shay Bujanover. The network helps show where Shay Bujanover may publish in the future.

Co-authorship network of co-authors of Shay Bujanover

This figure shows the co-authorship network connecting the top 25 collaborators of Shay Bujanover. A scholar is included among the top collaborators of Shay Bujanover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shay Bujanover. Shay Bujanover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krystal, Andrew D., Ruth M. Benca, Russell Rosenberg, et al.. (2022). Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression. Journal of Psychiatric Research. 155. 202–210. 18 indexed citations

Malhotra, Atul, Patrick J. Strollo, Jean‐Louis Pépin, et al.. (2022). Effects of solriamfetol treatment on body weight in participants with obstructive sleep apnea or narcolepsy. Sleep Medicine. 100. 165–173. 10 indexed citations

Ronnebaum, Sarah M., Morgan Bron, Dipen Patel, et al.. (2021). Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea. Journal of Clinical Sleep Medicine. 17(12). 2543–2555. 17 indexed citations

Reid, Michelle, Suzanne M. Bertisch, Morgan Bron, et al.. (2021). Prevalence of sleepiness and associations with quality of life in patients with sleep apnea in an online cohort. Journal of Clinical Sleep Medicine. 17(12). 2363–2372. 12 indexed citations

Rosenberg, Russell, Michael J. Thorpy, Yves Dauvilliers, et al.. (2021). Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy. Journal of Clinical Sleep Medicine. 18(1). 235–244. 8 indexed citations

Black, Jed, et al.. (2021). The Xyrem® (Sodium Oxybate) Risk Evaluation and Mitigation Strategy (REMS) Program in the USA: Results From 2016 to 2017. Drugs - Real World Outcomes. 8(1). 15–28. 11 indexed citations

Ben‐Joseph, Rami, et al.. (2021). 497 Clinical Presentation Prior to Idiopathic Hypersomnia Diagnosis Among US Adults: A Retrospective, Real-World Claims Analysis. SLEEP. 44(Supplement_2). A196–A196. 3 indexed citations

Husain, Aatif M., et al.. (2020). Incidence and duration of common, early-onset adverse events occurring during 2 randomized, placebo-controlled, phase 3 studies of sodium oxybate in participants with narcolepsy. Journal of Clinical Sleep Medicine. 16(9). 1469–1474. 6 indexed citations

Malhotra, Anita, Patrick J. Strollo, Jean‐Louis Pépin, et al.. (2020). 0641 Effects of Weight Loss During Long-Term Solriamfetol Treatment on Cardiometabolic Indices. SLEEP. 43(Supplement_1). A245–A245. 1 indexed citations

10.

Parthasarathy, Sairam, et al.. (2020). Understanding the burden of illness of excessive daytime sleepiness associated with obstructive sleep apnea: a qualitative study. Health and Quality of Life Outcomes. 18(1). 128–128. 27 indexed citations

11.

Strollo, Patrick J., Atul Malhotra, Kingman P. Strohl, et al.. (2020). 0772 Effects Of Solriamfetol On 24-hour Blood Pressure Patterns In Participants With Excessive Daytime Sleepiness Associated With Narcolepsy. SLEEP. 43(Supplement_1). A293–A293. 1 indexed citations

12.

Strollo, Patrick J., Atul Malhotra, Kingman P. Strohl, et al.. (2020). 0693 Effects Of Solriamfetol On 24-hour Blood Pressure Patterns In Participants With Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea. SLEEP. 43(Supplement_1). A264–A264. 2 indexed citations

13.

Stepnowsky, Carl, Kathleen Sarmiento, Shay Bujanover, et al.. (2019). Comorbidities, Health-Related Quality of Life, and Work Productivity Among People With Obstructive Sleep Apnea With Excessive Sleepiness: Findings From the 2016 US National Health and Wellness Survey. Journal of Clinical Sleep Medicine. 15(2). 235–243. 72 indexed citations

14.

Thorpy, Michael J., Kathleen F. Villa, Jed Black, et al.. (2018). The Nexus Narcolepsy Registry: Assessment of Sodium Oxybate (SXB) on Functioning, Productivity, and Health-Related Quality of Life in Participants With Narcolepsy (P1.105). Neurology. 90(15_supplement). 1 indexed citations

15.

Villa, Kathleen F., David J. Pasta, Jed Black, et al.. (2018). The Nexus Narcolepsy Registry: Factors Associated With Use of Different Medications and Discontinuation Rates in Participants With Narcolepsy (P1.106). Neurology. 90(15_supplement). 1 indexed citations

16.

Black, Jed, Shay Bujanover, Miriam G. Cisternas, et al.. (2017). 0651 ASSESSING THE BENEFITS OF SODIUM OXYBATE (SXB) ON FUNCTIONING, PRODUCTIVITY, AND HEALTH-RELATED QUALITY OF LIFE IN PEOPLE WITH NARCOLEPSY: FINDINGS FROM THE NEXUS NARCOLEPSY REGISTRY. SLEEP. 40(suppl_1). A241–A241. 1 indexed citations

17.

Mehta, Neel, et al.. (2016). Relationship between pain relief, reduction in pain-associated sleep interference, and overall impression of improvement in patients with postherpetic neuralgia treated with extended-release gabapentin. Health and Quality of Life Outcomes. 14(1). 54–54. 15 indexed citations

18.

Willens, Joyce S., Iwona Bucior, Shay Bujanover, & Neel Mehta. (2015). Assessment of rescue opioid use in patients with post-bunionectomy pain treated with diclofenac potassium liquid-filled capsules. Journal of Pain Research. 8. 53–53. 5 indexed citations

19.

Chen, Cuiping, Shay Bujanover, & Anita Gupta. (2015). Effect of dosing interval on pharmacokinetics of fentanyl pectin nasal spray from a crossover study. Journal of Opioid Management. 11(2). 139–146. 1 indexed citations

20.

Gewandter, Jennifer S., Michael McDermott, Andrew McKeown, et al.. (2014). Reporting of intention-to-treat analyses in recent analgesic clinical trials: ACTTION systematic review and recommendations. Pain. 155(12). 2714–2719. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact